• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病与溃疡严重程度对糖尿病相关足部溃疡患者心血管事件发生率的联合影响。

The combined impact of chronic kidney disease and ulcer severity on incident cardiovascular events in patients with diabetes-related foot ulceration.

作者信息

Lan Nick S R, Hiew Jonathan, Ferreira Ivana, Ritter J Carsten, Manning Laurens, Fegan P Gerry, Hamilton Emma J, Dwivedi Girish

机构信息

Centre of Excellence for Cardiometabolic Health, Fiona Stanley Hospital, Perth, Australia.

Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.

出版信息

Physiol Rep. 2025 Jun;13(11):e70415. doi: 10.14814/phy2.70415.

DOI:10.14814/phy2.70415
PMID:40474776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141929/
Abstract

In patients with diabetes-related foot ulceration (DFU), ulcer severity and chronic kidney disease (CKD) portend worse outcomes. We evaluated the combined impact of a severe ulcer with CKD on major adverse cardiovascular events (MACE) in patients with DFU. Ulcer severity was defined using the SINBAD (site, ischaemia, neuropathy, bacterial infection, area, depth) classification, dividing into low (1-3) or high (4-6). CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m. Patients were categorized into four groups based on SINBAD and CKD category. MACE was defined as hospitalization for myocardial infarction, stroke or transient ischemic attack, or heart failure. Of 497 patients, 236 (47.5%) were SINBAD-low/CKD-absent, 80 (16.1%) SINBAD-high/CKD-absent, 127 (25.6%) SINBAD-low/CKD-present, and 54 (10.9%) SINBAD-high/CKD-present. The median follow-up was 410 (interquartile range 242-576) days for MACE and 387 (221-549) days for MACE or all-cause mortality. SINBAD-high/CKD-present was associated with significantly higher MACE (SINBAD-low/CKD-absent 4.2%; SINBAD-high/CKD-absent 7.5%; SINBAD-low/CKD-present 9.5%; SINBAD-high/CKD-present 33.3%; log-rank p < 0.001) and MACE or all-cause mortality (SINBAD-low/CKD-absent 5.5%; SINBAD-high/CKD-absent 13.8%; SINBAD-low/CKD-present 17.4%; SINBAD-high/CKD-present 53.7%; log-rank p < 0.001). SINBAD-high/CKD-present was associated with MACE (p < 0.001) and MACE or all-cause mortality (p < 0.001) after multivariate adjustment. Severe DFU with CKD amplifies the risk of MACE in patients with DFU, suggesting important implications for cardiovascular risk assessment.

摘要

在糖尿病相关足部溃疡(DFU)患者中,溃疡严重程度和慢性肾脏病(CKD)预示着更差的预后。我们评估了严重溃疡合并CKD对DFU患者主要不良心血管事件(MACE)的综合影响。溃疡严重程度采用SINBAD(部位、缺血、神经病变、细菌感染、面积、深度)分类法进行定义,分为低(1 - 3)级或高(4 - 6)级。CKD定义为估计肾小球滤过率<60 mL/min/1.73 m²。根据SINBAD和CKD类别将患者分为四组。MACE定义为因心肌梗死、中风或短暂性脑缺血发作或心力衰竭住院。在497例患者中,236例(47.5%)为SINBAD低/无CKD,80例(16.1%)为SINBAD高/无CKD,127例(25.6%)为SINBAD低/有CKD,54例(10.9%)为SINBAD高/有CKD。MACE的中位随访时间为410天(四分位间距242 - 576天),MACE或全因死亡率的中位随访时间为387天(四分位间距221 - 549天)。SINBAD高/有CKD与显著更高的MACE发生率相关(SINBAD低/无CKD为4.2%;SINBAD高/无CKD为7.5%;SINBAD低/有CKD为9.5%;SINBAD高/有CKD为33.3%;对数秩检验p<0.001)以及MACE或全因死亡率相关(SINBAD低/无CKD为5.5%;SINBAD高/无CKD为13.8%;SINBAD低/有CKD为17.4%;SINBAD高/有CKD为53.7%;对数秩检验p<0.001)。多变量调整后,SINBAD高/有CKD与MACE(p<0.001)和MACE或全因死亡率(p<0.001)相关。严重DFU合并CKD会增加DFU患者发生MACE的风险,提示对心血管风险评估具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/12141929/5cfa2a08a6e6/PHY2-13-e70415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/12141929/d02157993bf5/PHY2-13-e70415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/12141929/5cfa2a08a6e6/PHY2-13-e70415-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/12141929/d02157993bf5/PHY2-13-e70415-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d179/12141929/5cfa2a08a6e6/PHY2-13-e70415-g001.jpg

相似文献

1
The combined impact of chronic kidney disease and ulcer severity on incident cardiovascular events in patients with diabetes-related foot ulceration.慢性肾脏病与溃疡严重程度对糖尿病相关足部溃疡患者心血管事件发生率的联合影响。
Physiol Rep. 2025 Jun;13(11):e70415. doi: 10.14814/phy2.70415.
2
Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.患有深度感染性糖尿病相关足部溃疡的患者发生重大不良心血管事件的风险增加。
Diabetologia. 2025 Feb;68(2):460-470. doi: 10.1007/s00125-024-06316-z. Epub 2024 Nov 7.
3
Use of the SINBAD score as a predicting tool for major adverse foot events in patients with diabetic foot ulcer: A French multicentre study.利用 SINBAD 评分作为预测糖尿病足溃疡患者主要足部不良事件的工具:一项法国多中心研究。
Diabetes Metab Res Rev. 2023 Nov;39(8):e3705. doi: 10.1002/dmrr.3705. Epub 2023 Jul 31.
4
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.用于慢性肾病和糖尿病患者的胰高血糖素样肽1(GLP-1)受体激动剂。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.
5
Cardiovascular and Kidney Outcomes of Non-Diabetic CKD by Albuminuria Severity: Findings From the CRIC Study.非糖尿病慢性肾脏病患者的白蛋白尿严重程度与心血管和肾脏结局:来自 CRIC 研究的结果。
Am J Kidney Dis. 2024 Dec;84(6):742-750.e1. doi: 10.1053/j.ajkd.2024.05.008. Epub 2024 Jul 19.
6
Cardiac Autonomic Neuropathy is Associated with Improved Diabetic Foot Ulcer Healing: A Single Centre Prospective Cohort Study.心脏自主神经病变与糖尿病足溃疡愈合改善相关:一项单中心前瞻性队列研究。
Exp Clin Endocrinol Diabetes. 2021 Dec;129(12):895-898. doi: 10.1055/a-1158-9130. Epub 2020 Jul 2.
7
Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.患有糖尿病且伴有或不伴有慢性肾病的患者使用二肽基肽酶-4 抑制剂与心血管事件风险相关:一项全国性队列研究。
PLoS One. 2019 May 21;14(5):e0215248. doi: 10.1371/journal.pone.0215248. eCollection 2019.
8
In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.慢性肾脏病患者慢性完全闭塞性经皮冠状动脉介入治疗的院内结局
J Invasive Cardiol. 2018 Nov;30(11):E113-E121. Epub 2018 Sep 15.
9
Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.在晚期 CKD 患者中,肾素-血管紧张素系统抑制剂和钙通道阻滞剂的疗效比较:一项全国性观察性队列研究。
Am J Kidney Dis. 2021 May;77(5):719-729.e1. doi: 10.1053/j.ajkd.2020.10.006. Epub 2020 Nov 24.
10
Ankle-brachial Index for the Prognosis of Cardiovascular Disease in Patients with Mild Renal Insufficiency.踝臂指数对轻度肾功能不全患者心血管疾病预后的影响
Intern Med. 2017 Aug 15;56(16):2103-2111. doi: 10.2169/internalmedicine.8215-16. Epub 2017 Aug 1.

本文引用的文献

1
Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.联合治疗作为糖尿病和非糖尿病慢性肾脏病的一种新的治疗标准。
Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i59-i69. doi: 10.1093/ndt/gfae258.
2
Unravelling the cardio-renal-metabolic-foot connection in people with diabetes-related foot ulceration: a narrative review.解析糖尿病相关足部溃疡患者的心脏-肾脏-代谢-足部关联:一项叙述性综述
Cardiovasc Diabetol. 2024 Dec 18;23(1):437. doi: 10.1186/s12933-024-02527-1.
3
Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.
患有深度感染性糖尿病相关足部溃疡的患者发生重大不良心血管事件的风险增加。
Diabetologia. 2025 Feb;68(2):460-470. doi: 10.1007/s00125-024-06316-z. Epub 2024 Nov 7.
4
Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management.新发糖尿病相关足部溃疡患者的死亡率:一项具有管理意义的队列研究。
Diabetologia. 2024 Dec;67(12):2691-2701. doi: 10.1007/s00125-024-06262-w. Epub 2024 Sep 27.
5
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.司美格鲁肽对 2 型糖尿病患者慢性肾脏病的影响。
N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.
6
Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease.基于风险加速实施2型糖尿病和慢性肾脏病的指南指导药物治疗
Circulation. 2024 Apr 16;149(16):1238-1240. doi: 10.1161/CIRCULATIONAHA.123.068524. Epub 2024 Apr 15.
7
Reliability of a Three-Dimensional Wound Camera for Measurement of Diabetes-Related Foot Ulcers in a Clinical Setting.三维伤口相机在临床环境中测量糖尿病相关足部溃疡的可靠性
J Diabetes Sci Technol. 2024 May;18(3):747-749. doi: 10.1177/19322968241233547. Epub 2024 Feb 24.
8
Diabetic foot ulcer is associated with cardiovascular-related mortality and morbidity - a systematic review and meta-analysis of 8062 patients.糖尿病足溃疡与心血管相关死亡率和发病率相关-8062 例患者的系统评价和荟萃分析。
Endocrine. 2024 Jun;84(3):852-863. doi: 10.1007/s12020-024-03696-5. Epub 2024 Jan 27.
9
Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.心血管病患者人群中糖尿病足溃疡的治疗和预防现状及原则:美国心脏协会的科学声明。
Circulation. 2024 Jan 23;149(4):e232-e253. doi: 10.1161/CIR.0000000000001192. Epub 2023 Dec 14.
10
Renal function is highly associated with podiatric risk in diabetic patients.肾功能与糖尿病患者的足部风险密切相关。
Clin Kidney J. 2023 May 11;16(11):2156-2163. doi: 10.1093/ckj/sfad106. eCollection 2023 Nov.